Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (600329.SS)
CNY 30.47
(0.36%)
CNY 30.47
(0.36%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | 1.09 Billion CNY | -22.56% |
| 2022 | 980.04 Million CNY | 13.08% |
| 2021 | 866.67 Million CNY | 10.38% |
| 2020 | 785.17 Million CNY | 3.45% |
| 2019 | 759.02 Million CNY | 18.31% |
| 2018 | 641.54 Million CNY | 21.88% |
| 2017 | 526.36 Million CNY | 25.04% |
| 2016 | 420.96 Million CNY | -15.64% |
| 2015 | 499.01 Million CNY | 20.74% |
| 2014 | 413.28 Million CNY | 2.04% |
| 2013 | 405.02 Million CNY | -18.98% |
| 2012 | 499.9 Million CNY | 84.1% |
| 2011 | 271.53 Million CNY | -11.18% |
| 2010 | 305.72 Million CNY | 46.26% |
| 2009 | 209.02 Million CNY | 112.88% |
| 2008 | 98.18 Million CNY | 256.6% |
| 2007 | -62.69 Million CNY | 83.08% |
| 2006 | -370.56 Million CNY | -553.57% |
| 2005 | 81.69 Million CNY | -9.41% |
| 2004 | 90.18 Million CNY | -3.6% |
| 2003 | 93.54 Million CNY | -8.17% |
| 2002 | 101.87 Million CNY | 24.98% |
| 2001 | 81.51 Million CNY | -15.74% |
| 2000 | 96.73 Million CNY | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | 355.41 Million CNY | 926.43% |
| 2024 Q2 | 242.07 Million CNY | -31.89% |
| 2024 Q3 | 171.58 Million CNY | -29.12% |
| 2023 Q1 | 454.59 Million CNY | 250.15% |
| 2023 Q4 | 34.62 Million CNY | -77.38% |
| 2023 FY | 758.95 Million CNY | -22.56% |
| 2023 Q3 | 153.05 Million CNY | -56.8% |
| 2023 Q2 | 354.29 Million CNY | -22.06% |
| 2022 Q3 | 298.94 Million CNY | -6.18% |
| 2022 Q2 | 318.63 Million CNY | 36.96% |
| 2022 FY | 980.04 Million CNY | 13.08% |
| 2022 Q1 | 232.64 Million CNY | 110.35% |
| 2022 Q4 | 129.82 Million CNY | -56.57% |
| 2021 Q3 | 220.96 Million CNY | -23.33% |
| 2021 Q4 | 110.59 Million CNY | -49.95% |
| 2021 FY | 866.67 Million CNY | 10.38% |
| 2021 Q1 | 246.92 Million CNY | 21.02% |
| 2021 Q2 | 288.19 Million CNY | 16.71% |
| 2020 Q1 | 194.66 Million CNY | -4.56% |
| 2020 FY | 785.17 Million CNY | 3.45% |
| 2020 Q2 | 203.62 Million CNY | 4.6% |
| 2020 Q3 | 182.84 Million CNY | -10.21% |
| 2020 Q4 | 204.03 Million CNY | 11.59% |
| 2019 Q3 | 159.02 Million CNY | -10.86% |
| 2019 Q1 | 217.63 Million CNY | 22.97% |
| 2019 Q2 | 178.38 Million CNY | -18.03% |
| 2019 FY | 759.02 Million CNY | 18.31% |
| 2019 Q4 | 203.97 Million CNY | 28.27% |
| 2018 Q3 | 110.44 Million CNY | -29.06% |
| 2018 FY | 641.54 Million CNY | 21.88% |
| 2018 Q4 | 176.98 Million CNY | 60.24% |
| 2018 Q1 | 198.42 Million CNY | 53.87% |
| 2018 Q2 | 155.68 Million CNY | -21.54% |
| 2017 Q4 | 128.96 Million CNY | 33.96% |
| 2017 Q3 | 96.26 Million CNY | -38.86% |
| 2017 Q2 | 157.45 Million CNY | 9.59% |
| 2017 FY | 526.36 Million CNY | 25.04% |
| 2017 Q1 | 143.67 Million CNY | 166.15% |
| 2016 Q1 | 130.96 Million CNY | 4.41% |
| 2016 Q4 | 53.98 Million CNY | -42.36% |
| 2016 FY | 420.96 Million CNY | -15.64% |
| 2016 Q3 | 93.64 Million CNY | -34.22% |
| 2016 Q2 | 142.36 Million CNY | 8.71% |
| 2015 FY | 499.01 Million CNY | 20.74% |
| 2015 Q4 | 125.43 Million CNY | 14.32% |
| 2015 Q3 | 109.72 Million CNY | -8.02% |
| 2015 Q2 | 119.28 Million CNY | -17.49% |
| 2015 Q1 | 144.56 Million CNY | 59.17% |
| 2014 Q3 | 75.27 Million CNY | -37.41% |
| 2014 Q2 | 120.27 Million CNY | -5.22% |
| 2014 Q1 | 126.9 Million CNY | 1.51% |
| 2014 FY | 413.28 Million CNY | 2.04% |
| 2014 Q4 | 90.82 Million CNY | 20.65% |
| 2013 Q3 | 55.45 Million CNY | -32.78% |
| 2013 Q4 | 125.01 Million CNY | 125.43% |
| 2013 Q1 | 142.05 Million CNY | 179.67% |
| 2013 Q2 | 82.49 Million CNY | -41.93% |
| 2013 FY | 405.02 Million CNY | -18.98% |
| 2012 Q4 | 50.79 Million CNY | -13.03% |
| 2012 Q1 | 168.65 Million CNY | 15422.65% |
| 2012 FY | 499.9 Million CNY | 84.1% |
| 2012 Q2 | 222.05 Million CNY | 31.67% |
| 2012 Q3 | 58.4 Million CNY | -73.7% |
| 2011 Q3 | 59.36 Million CNY | -21.86% |
| 2011 FY | 271.53 Million CNY | -11.18% |
| 2011 Q1 | 137.29 Million CNY | 1035.89% |
| 2011 Q2 | 75.97 Million CNY | -44.66% |
| 2011 Q4 | -1.1 Million CNY | -101.85% |
| 2010 Q3 | 79.59 Million CNY | -13.56% |
| 2010 Q2 | 92.07 Million CNY | -24.5% |
| 2010 Q1 | 121.96 Million CNY | 283.01% |
| 2010 Q4 | 12.08 Million CNY | -84.81% |
| 2010 FY | 305.72 Million CNY | 46.26% |
| 2009 Q1 | 92.19 Million CNY | 390.44% |
| 2009 FY | 209.02 Million CNY | 112.88% |
| 2009 Q4 | 31.84 Million CNY | -12.41% |
| 2009 Q3 | 36.35 Million CNY | -25.23% |
| 2009 Q2 | 48.62 Million CNY | -47.26% |
| 2008 Q2 | 46.34 Million CNY | -9.87% |
| 2008 Q3 | 32.16 Million CNY | -30.61% |
| 2008 Q4 | -31.74 Million CNY | -198.71% |
| 2008 Q1 | 51.42 Million CNY | 140.37% |
| 2008 FY | 98.18 Million CNY | 256.6% |
| 2007 Q3 | -14.51 Million CNY | -135.32% |
| 2007 Q4 | -127.38 Million CNY | -777.91% |
| 2007 FY | -62.69 Million CNY | 83.08% |
| 2007 Q1 | 38.11 Million CNY | 109.37% |
| 2007 Q2 | 41.08 Million CNY | 7.79% |
| 2006 Q3 | -12.18 Million CNY | -153.6% |
| 2006 Q1 | 25.79 Million CNY | 47.86% |
| 2006 Q4 | -406.9 Million CNY | -3240.17% |
| 2006 FY | -370.56 Million CNY | -553.57% |
| 2006 Q2 | 22.72 Million CNY | -11.89% |
| 2005 Q3 | 16.67 Million CNY | -45.25% |
| 2005 Q4 | 17.44 Million CNY | 4.61% |
| 2005 Q2 | 30.45 Million CNY | 77.82% |
| 2005 FY | 81.69 Million CNY | -9.41% |
| 2005 Q1 | 17.12 Million CNY | 203.88% |
| 2004 Q4 | 5.63 Million CNY | -67.04% |
| 2004 Q2 | 37 Million CNY | 21.59% |
| 2004 FY | 90.18 Million CNY | -3.6% |
| 2004 Q1 | 30.43 Million CNY | 98.33% |
| 2004 Q3 | 17.09 Million CNY | -53.8% |
| 2003 FY | 93.54 Million CNY | -8.17% |
| 2003 Q4 | 15.34 Million CNY | 102.0% |
| 2003 Q1 | 32.63 Million CNY | 231.6% |
| 2003 Q3 | 7.59 Million CNY | -79.99% |
| 2003 Q2 | 37.96 Million CNY | 16.33% |
| 2002 Q4 | 9.84 Million CNY | -66.24% |
| 2002 Q2 | 18.26 Million CNY | -59.06% |
| 2002 Q1 | 44.6 Million CNY | 0.0% |
| 2002 FY | 101.87 Million CNY | 24.98% |
| 2002 Q3 | 29.15 Million CNY | 59.65% |
| 2001 FY | 81.51 Million CNY | -15.74% |
| 2000 FY | 96.73 Million CNY | 0.0% |